|
Apr 25
|
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
|
|
Apr 24
|
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
|
|
Apr 24
|
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
|
|
Apr 22
|
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
|
|
Apr 22
|
UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
|
Apr 22
|
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
|
Apr 19
|
Butler Hall Capital urges Vanda to engage in sales discussions
|
|
Apr 18
|
Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
|
|
Apr 18
|
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
|
|
Apr 17
|
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
|
|
Apr 17
|
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
|
|
Apr 17
|
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
|
|
Apr 17
|
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
|
|
Apr 15
|
Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors
|
|
Apr 10
|
Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Apr 8
|
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
|
|
Apr 4
|
Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?
|
|
Apr 3
|
Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder
|
|
Apr 3
|
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
|
|
Apr 3
|
Why Is Vanda Pharmaceuticals Stock Trading Higher Today?
|